Brain-Specific tryptophan hydroxylase, TPH2, and 5-HTTLPR are associated with frontal lobe symptoms in alzheimer's disease

Journal of Alzheimer's Disease

Volumn 35, Issue 1, 2013, Pages 67-73

  Engelborghs, Sebastiaan ^a,b,d   Sleegers, Kristel ^b,c   Van Der Mussele, Stefan ^b,e   Le Bastard, Nathalie ^b   Brouwers, Nathalie ^b,c   Van Broeckhoven, Christine ^b,c   De Deyn, Peter Paul ^a,b,d  

^a Middelheim and Hoge Beuken General Hospitals (ZNA)   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d Hogeschool Antwerpen   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Alzheimer's disease; behavior; behavioral and psychological signs and symptoms of dementia (BPSD); dementia; serotonin; TPH2

Indexed keywords

SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE 2;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CIRCADIAN RHYTHM; DECISION MAKING; DEMENTIA; FEMALE; FOLLOW UP; FRONTAL LOBE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; INDEL MUTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM;

EID: 84876403413     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-101305     Document Type: Article

References (37)

1. SteinbergM, Sheppard JM, Tschanz JT, Norton MC, Steffens DC, Breitner JC, LyketsosCG(2003) The incidence of mental and behavioural disturbances in dementia: The cache county study. J Neuropsychiatry Clin Neurosci 15, 340-345. (Pubitemid 36999377)
2. Cummings JL, Zhong K (2006) Treatments for behavioral disorders in neurodegenerative disease: Drug development strategies. Nat Rev Drug Discov 5, 64-74.
3. Engelborghs S, De Deyn PP (1997) The neurochemistry of Alzheimer's disease. Acta Neurol Belg 97, 67-84. (Pubitemid 27293714)
4. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66, 2621-2624. (Pubitemid 26159101)
5. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Müller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP (1996) A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. Mol Psychiatry 1, 453-460. (Pubitemid 126439785)
6. Rocchi A, Micheli D, Ceravolo R, Manca ML, Tognoni G, Siciliano G, Murri L (2003) Serotonergic polymorphisms (5-HTTLPR and 5-HT2A): Association studies with psychosis in Alzheimer disease. Genet Test 7, 309-314. (Pubitemid 38199264)
7. Assal F, Alarcon M, Solomon EC, Masterman D, Geschwind DH, Cummings JL (2004) Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol 61, 1249-1253. (Pubitemid 39062679)
8. Ha TM, Cho DM, Park SW, Joo MJ, Lee BJ, Kong BG, Kim JM, Yoon JS, Kim YH (2005) Evaluating associations between 5-HTTLPR polymorphism and Alzheimer's disease for Korean patients. Dement Geriatr Cogn Disord 20, 31-34.
9. Micheli D, Bonvicini C, Rocchi A, Ceravolo R, Mancuso M, Tognoni G, Gennarelli M, Siciliano G, Murri L (2006) No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease. J Alzheimer Dis 10, 371-378.
10. Sukonick DL, Pollock BG, Sweet RA et al. (2001) The 5-HTTPR &z.ast;S/&z.ast;L polymorphism and aggressive behavior in Alzheimer disease. Arch Neurol 58, 1425-1428. (Pubitemid 32845994)
11. Sweet RA, Pollock BG, Sukonick DL et al. (2001) The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease. Int Psychogeriatr 13, 401-409. (Pubitemid 34326969)
12. Borroni B, GrassiM,Agosti C, Archetti S, Costanzi C, Cornali C, Caltagirone C, Caimi L, Di Luca M, Padovani A (2006) Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease. Am J Geriatr Psychiatry 14, 343-351.
13. Borroni B, Grassi M, Agosti C, Costanzi C, Archetti S, Franzoni S, Caltagirone C, Di Luca M, Caimi L, Padovani A (2006) Genetic correlates of behavioural endophenotypes in Alzheimer disease: Role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol Aging 27, 1595-1603. (Pubitemid 44363107)
14. Zhou Z, Roy A, Lipsky R, Kuchipudi K, Zhu G, Taubman J, Enoch MA, Virkkunen M, Goldman D (2005) Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch Gen Psychiatry 62, 1109-1118. (Pubitemid 41396936)
15. Van Den Bogaert A, Sleegers K, De Zutter S, Heyrman L, Norrback K-F, Adolfsson R, Van Broeckhoven C, Del-Favero J (2006) Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a northern Swedish, isolated population. Arch Gen Psychiatry 63, 1103-1110. (Pubitemid 44498389)
16. Lopez VA, Detera-Wadleigh S, Cardona I, Kassem L, The National Institute of Mental Health Genetics Initiative Bipolar Disorder Consortium, McMahon FJ (2007) Nested association between genetic variation in tryptophan hydroxylase II, bipolar affective disorder and suicide attempts. Biol Psychiatry 61, 181-186. (Pubitemid 46091659)
17. Engelborghs S, Maertens K, Nagels G, Vloeberghs E, Mariën P, Symons A, Ketels V, Estercam S, Somers N, De Deyn PP (2005) Neuropsychiatric symptoms of dementia. Crosssectional analysis from a prospective, longitudinal Belgian study. Int J Geriatr Psychiatry 20, 1028-1037. (Pubitemid 41723573)
18. Engelborghs S, Dermaut B, Mariën P, Symons A, Vloeberghs E, Maertens K, Somers N, Goemanx J, Rademakers R, Van den Broeck M, Pickut BA, Cruts M, Van Broeckhoven C, De Deyn PP (2006) Dose dependent effect of APOE ε4 on behavioral symptoms in frontal lobe dementia patients. Neurobiol Aging 27, 285-292. (Pubitemid 43038553)
19. De Deyn PP, Goeman J, Saerens J, Engelborghs S,Verstraeten S, Mariën P, D'Hooge R, Pickut BA (2003) The concept memory clinic: Historical perspective and objectives. In Memory: Basic Concepts, Disorders and Treatment, De Deyn PP, Thiery E, D'Hooge R, eds. Acco, Leuven, pp. 33-44.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
21. American Psychiatric Association. (1994) DSM-IV: Diagnostic and Statistical Manual Of Mental Disorders. American Psychiatric Association, Washington DC.
22. Folstein M, Folstein S, McHugh PR (1975) Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12, 189-196.
23. Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The Global Deterioration Scale (GDS) for assessment of primary degenerative dementia. Am J Psychiatry 139, 1136-1139. (Pubitemid 12051593)
24. De Deyn PP, Engelborghs S, Saerens J, Goeman J, Mariën P, Maertens K, Nagels G, Martin JJ, Pickut BA (2005) The Middelheim Frontality Score:Abehavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease. Int J Geriatr Psychiatry 20, 70-79. (Pubitemid 40089567)
25. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A (1987) Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment. J Clin Psychiatry 48(Suppl 5), 9-15. (Pubitemid 17091427)
26. Engelborghs S, Sleegers K, Cras P, Brouwers N, Serneels S, De Leenheir E, Martin J-J, Vanmechelen E, Van Broeckhoven C, De Deyn PP (2007) No association of CSF biomarkers with APOE 4, plaque and tangle burden in definite Alzheimer's disease. Brain 130, 2320-2326. (Pubitemid 47327622)
27. Cichon S,Winge I, Mattheisen M et al. (2008) Brain-specific tryptophan hydroxylase 2 (TPH2): A functional Pro206Ser substitution and variation in the 5′-region are associated with bipolar affective disorder. Hum Mol Genet 17, 87-97.
28. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265. (Pubitemid 40202029)
29. Kennedy MA,Miller AL, Rogers G, Luty S, Mulder R, Joyce P (2003) Polymorphic variants and association analysis of TPH2, brain tryptophan hydroxylase. Am J Med Genet B Neuropsychiatr Gene 122, 69.
30. Scheuch K, Lautenschlager M, Grohmann M, Stahlberg S, Kirchheiner J, Zill P, Heinz A, Walther D, Priller J (2007) Characterization of a functional promoter polymorphism of the human tryptophan hydroxylase 2 gene in serotonergic raphe neurons. Biol Psychiatry 62, 1288-1294. (Pubitemid 350060888)
31. McKinney JA, Turel B, Winge I, Knappskog PM, Haavik J (2009) Functional properties of missense variants of human tryptophan hydroxylase 2. Hum Mutat 30, 787-794.
32. Walther DJ, Bader M (2003) A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 66, 1673-1680. (Pubitemid 37249312)
33. Engelborghs S, De Vreese K, Van de Casteele T, Vanderstichele H,Van Everbroeck B, Cras P, Martin JJ,Vanmechelen E, De Deyn PP (2008) Diagnostic performance of a CSFbiomarker panel in autopsy-confirmed dementia. Neurobiol Aging 29, 1143-1159. (Pubitemid 351822410)
34. Aries MJH, Le Bastard N, Debruyne H, Van Buggenhout M, Nagels G, De Deyn PP, Engelborghs S (2010) Relation between frontal lobe symptoms and dementia severity across diagnostic categories. Int J Geriatr Psychiatry 25, 1186-1195.
35. Rabinowitz J, Katz IR, De Deyn PP, Brodaty H, Greenspan A, Davidson M (2004) Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone. J Clin Psychiatry 65, 1329-1334.
36. Cummings JL (1993) Frontal-subcortical circuits and human behavior. Arch Neurol 50, 873-880. (Pubitemid 23229317)
37. Mega MS, Cummings JL (1994) Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 6, 358-370. (Pubitemid 24344856)